These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27196354)

  • 21. High prevalence of unawareness of HCV infection status among both HCV-seronegative and seropositive people living with human immunodeficiency virus in Taiwan.
    Lee CY; Wu PH; Lu MW; Chen TC; Lu PL
    PLoS One; 2021; 16(5):e0251158. PubMed ID: 33956867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV and HCV coinfection: prevalence, associated factors and genotype characterization in the Midwest Region of Brazil.
    Freitas SZ; Teles SA; Lorenzo PC; Puga MA; Tanaka TS; Thomaz DY; Martins RM; Druzian AF; Lindenberg AS; Torres MS; Pereira SA; Villar LM; Lampe E; Motta-Castro AR
    Rev Inst Med Trop Sao Paulo; 2014; 56(6):517-24. PubMed ID: 25351547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review.
    Tengan FM; Ibrahim KY; Dantas BP; Manchiero C; Magri MC; Bernardo WM
    BMC Infect Dis; 2016 Nov; 16(1):663. PubMed ID: 27829381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
    Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing Epidemiology of Hepatitis B Virus and Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus-Positive Population in China: Results From the Third and Fourth Nationwide Molecular Epidemiologic Surveys.
    Liu L; Wang L; Zhang H; Ou W; Li D; Feng Y; Zhuang H; Shao Y
    Clin Infect Dis; 2021 Aug; 73(4):642-649. PubMed ID: 34398954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Med Virol; 2016 Mar; 88(3):487-97. PubMed ID: 26271205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
    Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential prevalence and geographic distribution of hepatitis C virus genotypes in acute and chronic hepatitis C patients in Vietnam.
    Le Ngoc C; Tran Thi Thanh T; Tran Thi Lan P; Nguyen Mai T; Nguyen Hoa T; Nghiem My N; Le Van T; Le Manh H; Le Thanh P; Nguyen Van Vinh C; Thwaites G; Cooke G; Heilek GM; Shikuma C; Le T; Baker S; Rahman M;
    PLoS One; 2019; 14(3):e0212734. PubMed ID: 30865664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus Among People Who Inject Drugs-Do Gender-Based Differences Vary by Country-Level Indicators?
    Leung J; Peacock A; Colledge S; Grebely J; Cunningham EB; Hickman M; Vickerman P; Stone J; Trickey A; Dumchev K; Lynskey M; Hines L; Griffiths P; Mattick RP; Degenhardt L; Larney S
    J Infect Dis; 2019 Jun; 220(1):78-90. PubMed ID: 30726973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.
    Martinello M; Hajarizadeh B; Grebely J; Dore GJ; Matthews GV
    Curr HIV/AIDS Rep; 2017 Jun; 14(3):110-121. PubMed ID: 28432579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial.
    Doyle JS; van Santen DK; Iser D; Sasadeusz J; O'Reilly M; Harney B; Traeger MW; Roney J; Cutts JC; Bowring AL; Winter R; Medland N; Fairley CK; Moore R; Tee BK; Asselin J; El-Hayek C; Hoy JF; Matthews GV; Prins M; Stoové MA; Hellard ME
    Clin Infect Dis; 2021 Oct; 73(7):e2164-e2172. PubMed ID: 33010149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virological Mechanisms in the Coinfection between HIV and HCV.
    Liberto MC; Zicca E; Pavia G; Quirino A; Marascio N; Torti C; Focà A
    Mediators Inflamm; 2015; 2015():320532. PubMed ID: 26494946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
    Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA
    BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.
    Rusine J; Ondoa P; Asiimwe-Kateera B; Boer KR; Uwimana JM; Mukabayire O; Zaaijer H; Mugabekazi J; Reiss P; van de Wijgert JH
    PLoS One; 2013; 8(5):e63303. PubMed ID: 23717409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological distribution and genotype characterization of hepatitis C virus and HIV co-infection in Wuhan, China, where the prevalence of HIV is low.
    Zhao R; Peng J; Tang L; Huang H; Liu M; Kong W; Pang B
    J Med Virol; 2013 Oct; 85(10):1712-23. PubMed ID: 23868809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of Hepatitis B Among HIV-infected Children and Adolescents Receiving Antiretroviral Therapy in the TREAT Asia Pediatric HIV Observational Database.
    Aurpibul L; Kariminia A; Vibol U; Fong MS; Le ON; Hansudewechakul R; Bunupuradah T; Kurniati N; Chokephaibulkit K; Kumarasamy N; Wati DK; Yusoff NKN; Razali KAM; Nallusamy RA; Sohn AH; Lumbiganon P;
    Pediatr Infect Dis J; 2018 Aug; 37(8):788-793. PubMed ID: 29846357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009.
    Zhou S; Zhao Y; He Y; Li H; Bulterys M; Sun X; Dou Z; Robinson M; Zhang F
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):191-6. PubMed ID: 20032784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B/C and HIV in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis.
    Barth RE; Huijgen Q; Taljaard J; Hoepelman AI
    Int J Infect Dis; 2010 Dec; 14(12):e1024-31. PubMed ID: 20870439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.